Deep Learning-Based Retinal Imaging Screening Tool for Preclinical Alzheimer’s Disease
About This Grant
PROJECT SUMMARY/ABSTRACT Alzheimer's disease (AD) imposes a substantial burden on the aging population, with projected costs surpassing $1 trillion by 2050. Mounting evidence supports the notion that targeting AD in its preclinical phase holds the greatest potential for effective interventions and substantial social benefits. However, identifying individuals at risk for preclinical AD in routine clinical practice or for inclusion in trials currently relies on diagnostic modalities with limited availability and affordability. While PET, cerebrospinal fluid analysis, structural MRI, and emerging blood-based biomarkers (BBBM) for AD pathology (amyloid (A), tau (T), neurodegeneration (N), and inflammation (I)) have advanced the field, they remain constrained by high cost, invasiveness, or the need for further validation. An easily accessible extension of the central nervous system, the retina, exhibits amyloid and tau deposition, vascular alterations, inflammation, and other neurodegenerative changes that mirror brain pathology. Non-mydriatic retinal color fundus photography (CFP) is a low-cost, non-invasive modality that enables repeated, large-scale imaging. Despite its promise, CFP analysis in preclinical AD remains underexplored, partly due to challenges in image quality and the lack of validated automated diagnostic tools. Meanwhile, deep learning (DL) enabled automated detection of retinal CFP biomarkers for conditions such as diabetic retinopathy, leading to FDA-cleared algorithms deployed in primary care settings. This project will develop and validate a suite of DL methods to enhance CFP image quality, automate retinal AD biomarker identification, and enable scalable, cost-effective preclinical AD risk assessment. Specifically, we will: (1) develop an unsupervised method using optimal transport-guided generative adversarial networks with domain adaptation to enhance low quality CFPs; (2) build nn-MobileNet++, a lightweight DL model combining attention, dynamic convolution, and hybrid modules for AD retinal biomarker detection; and (3) evaluate predictive performance of CFP alone, BBBM alone, and integrated CFP+BBBM models to predict PET- and BBBM-defined central nervous system (CNS) amyloid positivity. We will also explore DL-based retinal age gap and cognitive prediction as novel AD biomarkers. We will leverage three large-scale datasets: UK Biobank, Canadian Longitudinal Study on Aging, and Mayo AD databases. The Mayo Preclinical AD cohort, a cohort of 100 preclinical AD patients (cognitively unimpaired (CU), amyloid PET positive) and their age- and gender-matched 230 controls (CU, amyloid PET negative), will serve as a primary testbed, leveraging retinal imaging data alongside genetic, brain imaging, BBBM, and clinical information. External validation will be performed in the rural, point-of-care MindCrowd MobileLab cohort (n > 1,000 with retinal and brain imaging, genetics, cognitive testing, BBBM). By integrating cutting-edge DL models with rich multimodal datasets, this project aims to create a robust, accessible platform for non-invasive preclinical AD detection, facilitating earlier diagnosis, enabling large-scale trial recruitment, and ultimately helping reduce clinical trial costs and accelerating the development of effective AD therapies.
Grant Summary
Deep Learning-Based Retinal Imaging Screening Tool for Preclinical Alzheimer’s Disease is a NIA - National Institute on Aging grant providing up to $656K for university, nonprofit, healthcare org. Applications are due 2031-05-31 (open). Check eligibility and apply with FindGrants.
Not quite the right fit?
Search 9,000+ open grants, or get matches ranked for your organization — free.
Focus Areas
Eligibility
How to Apply
Up to $656K
2031-05-31
- 1Confirm your organization is eligible for Deep Learning-Based Retinal Imaging Screening Tool for Preclinical Alzheimer’s Disease from NIA - National Institute on Aging, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NIA - National Institute on Aging before the deadline.
Don't want to draft it yourself?
We'll draft the complete application against NIA - National Institute on Aging's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
Deep Learning-Based Retinal Imaging Screening Tool for Preclinical Alzheimer’s Disease: Frequently Asked Questions
Who is eligible for the Deep Learning-Based Retinal Imaging Screening Tool for Preclinical Alzheimer’s Disease?
Deep Learning-Based Retinal Imaging Screening Tool for Preclinical Alzheimer’s Disease is offered by NIA - National Institute on Aging and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the Deep Learning-Based Retinal Imaging Screening Tool for Preclinical Alzheimer’s Disease provide?
Deep Learning-Based Retinal Imaging Screening Tool for Preclinical Alzheimer’s Disease provides up to $656K per award from NIA - National Institute on Aging. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the Deep Learning-Based Retinal Imaging Screening Tool for Preclinical Alzheimer’s Disease deadline?
Applications for Deep Learning-Based Retinal Imaging Screening Tool for Preclinical Alzheimer’s Disease are due 2031-05-31 (open). Because deadlines can change, verify the date with the funder, NIA - National Institute on Aging, and give yourself enough time to prepare a complete, competitive application before the close date.
How do you apply for the Deep Learning-Based Retinal Imaging Screening Tool for Preclinical Alzheimer’s Disease?
To apply for Deep Learning-Based Retinal Imaging Screening Tool for Preclinical Alzheimer’s Disease, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NIA - National Institute on Aging.